CPH:CC News and Press, Cipher Pharmaceuticals Inc. From 03/10/23

Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , March 10, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced that it will release its fina...

Cipher Pharmaceuticals Announces Closing of New US$35 Million Credit Facility Canada NewsWire MISSISSAUGA, ON , March 1, 2023 /CNW/ - Feb 28 , 2023 - Cipher Pharmaceuticals Inc . (TSX: CPH) (" Cipher " or " the Company ") today announced comp...

Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per Share Canada NewsWire (All figures are presented in U.S. dollars) EPS increased YoY by $0.08 to $0.11 in the third quarter; Strengthened balance s...

CIPHER PHARMACEUTICALS SCHEDULES Q3 2022 EARNINGS RELEASE AND CONFERENCE CALL Canada NewsWire OAKVILLE, ON , Oct. 26, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced that it will release its Q3 20...

Cipher Pharmaceuticals Announces Normal Course Issuer Bid Canada NewsWire MISSISSAUGA, ON , Sept. 19, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or the "Company") announced today that it has filed, and the Toronto Stock Exchange (the "T...

Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFO Canada NewsWire Experienced finance executive Bryan Jacobs , CPA, CA to join the Company as CFO, effective August 15, 2022 . OAKVILLE, ON , Aug. 11, 2022 /CNW/ - Ci...

Cipher Pharmaceuticals Reports Second Quarter 2022 Financial Results Canada NewsWire (All figures are in U.S. dollars) Drove 7% increase in product revenue to $3.5 million Generated $3.6 million in Adjusted EBITDA Total operating expen...

Cipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , Aug. 5, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or " the Company ") today announced that it will release its Q2...

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John Mull Canada NewsWire MISSISSAUGA, ON , June 22, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or the " Company ")...

Cipher Pharmaceuticals Reports Strong First Quarter 2022 Financial Results Canada NewsWire (All figures are in U.S. dollars) Drove 60% increase in EPS to $0.08 Demonstrated a focus on execution as EBITDA increased 38% to $3.1 million T...